scholarly journals Additive intraocular pressure-lowering effect of dorzolamide 1%/timolol 0.5% fixed combination on prostaglandin monotherapy in patients with normal tension glaucoma

2011 ◽  
pp. 1515 ◽  
Author(s):  
Takanori Mizoguchi
Keyword(s):  
Intraocular Pressure ◽  
Fixed Combination ◽  
Normal Tension Glaucoma ◽  
Lowering Effect ◽  
Pressure Lowering

Intraocular Pressure–lowering Efficacy of Dorzolamide/Timolol Fixed Combination in Normal-tension Glaucoma

2014 ◽  
Vol 23 (5) ◽  
pp. 329-332 ◽  
Author(s):  
Tae-Woo Kim ◽  
Martha Kim ◽  
Eun Ji Lee ◽  
Jin Wook Jeoung ◽  
Ki Ho Park
Keyword(s):  
Intraocular Pressure ◽  
Fixed Combination ◽  
Normal Tension Glaucoma ◽  
Pressure Lowering

Meeting Summary

2007 ◽  
Vol 17 (5_suppl) ◽  
pp. 28-30 ◽  
Author(s):  
C. Migdal
Keyword(s):  
Patient Satisfaction ◽  
Intraocular Pressure ◽  
Combination Therapy ◽  
Fixed Combination ◽  
Mechanisms Of Action ◽  
High Patient Satisfaction ◽  
Lowering Effect

Several fixed combination products are now available in glaucoma management. Considerations when selecting combination therapy include safety, finding the best combination of mechanisms of action. Combigan® is one such product that has been shown to be more effective than either of its constituent agents, brimonidine or timolol, used alone. It has at least a similar intraocular pressure (IOP)-lowering effect as the concomitant use of its two constituents, and it produces a significant additional lowering of IOP in patients who switch from other therapies, including Cosopt®. Combigan has high patient satisfaction ratings.

Intraocular Pressure–Lowering Effect of 0.005% Latanoprost with Two Different Dosing Regimens

2012 ◽  
Vol 28 (5) ◽  
pp. 524-528 ◽  
Author(s):  
Naveed Nilforushan ◽  
Ali Naghibi ◽  
Siamak Shokrollahi ◽  
Mostafa Soltan Sanjari ◽  
Kouros Nouri-Mahdavi
Keyword(s):  
Intraocular Pressure ◽  
Lowering Effect ◽  
Pressure Lowering ◽  
Dosing Regimens
Sign in / Sign up

Export Citation Format

Share Document